Vor Biopharma Ownership | Who Owns Vor Biopharma?

Vor Biopharma Ownership Summary

Vor Biopharma is owned by 89.00% institutional investors, 32.04% insiders. Ra capital management is the largest institutional shareholder, holding 57.91% of VOR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.10% of its assets in Vor Biopharma shares.

VOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vor Biopharma	89.00%	32.04%	-21.03%
Sector	Healthcare Stocks	57.39%	9.93%	32.68%
Industry	Biotech Stocks	68.48%	9.65%	21.87%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	39.65M	57.91%	$44.01M
Fmr	6.42M	9.38%	$7.13M
5am venture management	6.36M	9.29%	$7.06M
Vanguard group	1.94M	2.84%	$2.16M
Johnson & johnson	1.07M	1.57%	$1.19M
Lynx1 capital management lp	637.22K	0.93%	$707.31K
Sarissa capital management lp	618.00K	0.90%	$685.98K
Renaissance	529.50K	0.77%	$587.75K
Blackrock	497.70K	0.73%	$497.70K
Blackrock funding, inc. /de	488.36K	0.71%	$542.08K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
5am venture management	6.36M	1.69%	$7.06M
Ra capital management	39.65M	0.59%	$44.01M
Johnson & johnson	1.07M	0.31%	$1.19M
Lynx1 capital management lp	637.22K	0.27%	$707.31K
Sarissa capital management lp	618.00K	0.21%	$685.98K
Trustees of columbia university in the city of new york	91.91K	0.02%	$102.02K
Point72 asia (singapore) pte.	28.09K	0.01%	$31.18K
Xtx topco	71.79K	0.01%	$79.69K
Gabelli & co investment advisers	30.00K	0.01%	$33.30K
Exchange traded concepts	165.81K	0.00%	$184.04K

Top Buyers

Holder	Shares	% Assets	Change
Ra capital management	39.65M	0.59%	16.90M
Lynx1 capital management lp	637.22K	0.27%	637.22K
Susquehanna group, llp	115.03K	-	115.03K
Trustees of columbia university in the city of new york	91.91K	0.02%	91.91K
Xtx topco	71.79K	0.01%	71.79K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-6.46M
Hudson bay capital management lp	-	-	-2.47M
Blackrock	497.70K	-	-1.75M
Woodline partners lp	-	-	-1.11M
Artal group	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Lynx1 capital management lp	637.22K	0.27%	637.22K	$707.31K
Trustees of columbia university in the city of new york	91.91K	0.02%	91.91K	$102.02K
Xtx topco	71.79K	0.01%	71.79K	$79.69K
Gabelli & co investment advisers	30.00K	0.01%	30.00K	$33.30K
Sei investments	17.60K	-	17.60K	$17.60K

Sold Out

Holder	Change
Nbc securities	-1.00
Nelson, van denburg & campbell wealth management group	-6.00
Nisa investment advisors	-45.00
Citadel advisors	-100.00
Smartleaf asset management	-102.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2024	52	-5.45%	60,931,305	27.38%	88	1.82%	20	11.11%	16	-11.11%
Sep 30, 2024	55	-19.12%	47,833,717	-12.27%	69	1.09%	19	-51.28%	18	5.88%
Jun 30, 2024	68	-2.86%	54,521,316	-7.51%	80	1.04%	39	34.48%	17	-19.05%
Mar 31, 2024	70	14.75%	58,949,485	-1.10%	87	1.13%	29	7.41%	21	50.00%
Dec 31, 2023	61	-	59,603,001	-1.01%	88	1.09%	27	35.00%	14	-12.50%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.12M	3.10%	-
Fidelity Growth Compy Commingled Pl S	2.17M	1.74%	3.11K
Fidelity Growth Company Fund	1.41M	1.13%	-
Vanguard Total Stock Mkt Idx Inv	1.39M	1.11%	-
Vanguard US Total Market Shares ETF	1.39M	1.11%	-
Fidelity Select Biotechnology	614.60K	0.90%	-
Fidelity VIP Growth Initial	618.39K	0.50%	-
Fidelity Capital Appreciation	610.40K	0.49%	-
Vanguard Institutional Extnd Mkt Idx Tr	519.63K	0.42%	-
Fidelity Growth Company K6	481.91K	0.39%	-12.31K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Feb 13, 2025	Attar Eyal C.	CHIEF MEDICAL OFFICER	Sell	$3.16K
Feb 10, 2025	Attar Eyal C.	CHIEF MEDICAL OFFICER	Sell	$3.50K
Dec 30, 2024	Reprogrammed Interchange LLC	-	Buy	$38.75M
Dec 30, 2024	Reprogrammed Interchange LLC	-	Buy	$40.83M
Dec 27, 2024	Attar Eyal C.	CHIEF MEDICAL OFFICER	Sell	$12.92K

Insider Transactions Trends

Date	Buy	Sell
2025 Q1	-	1
2024 Q4	2	1
2024 Q3	-	-
2024 Q2	-	1
2024 Q1	-	-

VOR Ownership FAQ

Who Owns Vor Biopharma?

Vor Biopharma shareholders are primarily institutional investors at 89.00%, followed by 32.04% insiders and -21.04% retail investors. The average institutional ownership in Vor Biopharma's industry, Biotech Stocks , is 68.48%, which Vor Biopharma exceeds.

Who owns the most shares of Vor Biopharma?

Vor Biopharma’s largest shareholders are Ra capital management (39.65M shares, 57.91%), Fmr (6.42M shares, 9.38%), and 5am venture management (6.36M shares, 9.29%). Together, they hold 76.57% of Vor Biopharma’s total shares outstanding.

Does Blackrock own Vor Biopharma?

Yes, BlackRock owns 0.73% of Vor Biopharma, totaling 497.7K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 497.7K$. In the last quarter, BlackRock decreased its holdings by -1.75M shares, a -77.86% change.

Who is Vor Biopharma’s biggest shareholder by percentage of total assets invested?

5am venture management is Vor Biopharma’s biggest shareholder by percentage of total assets invested, with 1.69% of its assets in 6.36M Vor Biopharma shares, valued at 7.06M$.

Who is the top mutual fund holder of Vor Biopharma shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Vor Biopharma shares, with 3.10% of its total shares outstanding invested in 2.12M Vor Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools